Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma

Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma

Transarterial chemoembolization (TACE) is the most commonly used treatment for advanced hepatocellular carcinoma (HCC), but still lacks accurate real‐time biomarkers for monitoring its therapeutic efficacy. Here, we explored whether copy number profiling of circulating free DNA (cfDNA) could be util...

Full description

Bibliographic Details
Main Authors: Xiuqing Dong, Geng Chen, Xinghui Huang, Zhenli Li, Fang Peng, Hengkai Chen, Yang Zhou, Lei He, Liman Qiu, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Molecular Oncology
Subjects:
circulating free DNA
copy number variants
hepatocellular carcinoma
transarterial chemoembolization
tumour fraction
Online Access:https://doi.org/10.1002/1878-0261.13170

Internet

https://doi.org/10.1002/1878-0261.13170

Similar Items